Continued research and Clinical trials are being monitored by our CRO – CPI. As of late 2019 we will expand our research facilities at the University of Antwerp Science Park in Niel, Belgium and we are presently looking at new facilities in Málaga, Spain. Extensive medical research is taking place in Belgium, and partnerships are planned to be further developed in and outside of Europe, in particularly at the Hospital de la Familia in Juarez Mexico and Virucease USA in Dallas, Texas.
The Financial Head Quarters and key research remain in Luxembourg.